Biochemical Basis for the Antagonism between Aminoglutethimide and Danazol in the Endocrine Treatment of Breast Cancer
article
OA: closed
CC0
AI-generated summary
The combination of aminoglutethimide and danazol showed reduced breast cancer patient response compared to aminoglutethimide alone due to danazol's suppression of sex hormone binding-globulin leading to increased free estradiol.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Only 13% of postmenopausal advanced breast cancer patients responded to endocrine treatment with aminoglutethimide plus danazol whilst 33% responded to aminoglutethimide alone, despite a similar suppression of serum oestradiol levels in the two groups. The patients on aminoglutethimide and danazol showed a marked suppression of sex hormone binding-globulin binding capacity and a consequent rise in percent-free oestradiol. This led to the concentration of free oestradiol being less well suppressed than that of total oestradiol and in some patients free oestradiol concentrations were higher on treatment than before. Patients on aminoglutethimide alone showed no change in the binding of oestradiol and the percentage suppression of the free oestradiol concentration was similar to that of total oestradiol. The opposing effects of danazol and aminoglutethimide on the concentration of the free, biologically active fraction of oestradiol in the circulation may explain the poor therapeutic efficacy of this combination in breast cancer patients.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (4)
- A Comparison of Plasma Protein Changes Induced by Danazol, Pregnancy, and Estrogens* 1979
- Endocrine effects of danazol in the treatment of endometriosis 1984
- Changes in the shbg concentration during danazol treatment 1984
- Tamoxifen, aminoglutethimide and danazol: effect of therapy on hormones in post-menopausal patients with breast cancer 1982
References (20)
- A Comparison of Plasma Protein Changes Induced by Danazol, Pregnancy, and Estrogens* via openalex
- Changes in the shbg concentration during danazol treatment via openalex
- Endocrine effects of danazol in the treatment of endometriosis via openalex
- Tamoxifen, aminoglutethimide and danazol: effect of therapy on hormones in post-menopausal patients with breast cancer via openalex
- doi:10.1038/bjc.1983.100 via openalex
- doi:10.1111/j.1365-2265.1974.tb03298.x via openalex
- doi:10.1016/b978-0-12-571138-8.50016-0 via openalex
- doi:10.1210/edrv-2-1-103 via openalex
- doi:10.1210/jcem-47-6-1257 via openalex
- doi:10.1016/0022-4731(82)90041-3 via openalex
- doi:10.1111/j.1365-2265.1985.tb01083.x via openalex
- doi:10.1016/s0021-9258(19)70742-x via openalex
- doi:10.1016/0022-4731(77)90196-0 via openalex
- doi:10.1111/j.1365-2265.1985.tb00228.x via openalex
- doi:10.1016/0022-4731(84)90290-5 via openalex
- doi:10.1210/jcem-27-9-1239 via openalex
- doi:10.1210/jcem-36-2-207 via openalex
- doi:10.1002/bjs.1800670302 via openalex
- doi:10.1016/0305-7372(84)90033-1 via openalex
- doi:10.1016/0305-7372(84)90008-2 via openalex
Source provenance
- openalex
- last seen: 2026-05-10T12:02:58.567994+00:00
License: CC0
· commercial use OK